NCT07070726

Brief Summary

The goal of this study is to comprehensively measure ongoing concerns and unmet needs of individuals living with ovarian cancer. To accomplish this, the UNderstanding The experience of Ovarian cancer - Life after Diagnosis (UNTOLD) study will be conducted using a mixed-methods approach. Ovarian cancer survivors will be enrolled to participate in UNTOLD to complete a one-time survey regarding their experiences. Up to 40 survivors will be subsequently identified to complete a follow-up interview. To ensure these sample sizes, along with a representative sample, a combined recruitment strategy will be employed using the California Cancer Registry (population-based) and recruitment through ovarian cancer advocacy groups.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
21mo left

Started Jul 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Jul 2025Jan 2028

First Submitted

Initial submission to the registry

July 8, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

July 10, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 17, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

July 20, 2025

Status Verified

July 1, 2025

Enrollment Period

12 months

First QC Date

July 8, 2025

Last Update Submit

July 16, 2025

Conditions

Ovarian Cancer

Keywords

ovarian cancerquality of lifecancer survivorship

Outcome Measures

Primary Outcomes (1)

  • Supportive Care Needs

    Composite Supportive Care Needs Survey - Short Form (SCNS-SF34) score minimum: 34, maximum: 170; continuous score; presented as mean and standard deviation.

    Day 1

Secondary Outcomes (1)

  • Quality of Life - Average FACT general total score

    Day 1

Study Arms (1)

Ovarian Cancer Survivors

Ovarian cancer survivors participate in UNTOLD by completing a one-time survey regarding their experiences

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Ovarian cancer survivors will be enrolled to participate in UNTOLD to complete a one-time survey regarding their experiences.

You may qualify if:

  • Ability to read and write in English
  • Diagnosed with ovarian cancer (ovarian, primary peritoneal, fallopian tube)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Masonic Cancer Center

Minneapolis, Minnesota, 55455, United States

RECRUITING

MeSH Terms

Conditions

Ovarian Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal Disorders

Central Study Contacts

Rachel Vogel, PhD

CONTACT

612-624-6928isak0023@umn.edu

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2025

First Posted

July 17, 2025

Study Start

July 10, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

January 1, 2028

Last Updated

July 20, 2025

Record last verified: 2025-07

Locations

US(1)